161 related articles for article (PubMed ID: 12210067)
21. Highly sensitive analysis for N-myc amplification in neuroblastoma based on fluorescence in situ hybridization.
Tajiri T; Shono K; Fujii Y; Noguchi S; Kinoshita Y; Tsuneyoshi M; Suita S
J Pediatr Surg; 1999 Nov; 34(11):1615-9. PubMed ID: 10591554
[TBL] [Abstract][Full Text] [Related]
22. Detection of N-myc oncogene expression in human neuroblastoma by in situ hybridization and blot analysis: relationship to clinical outcome.
Grady-Leopardi EF; Schwab M; Ablin AR; Rosenau W
Cancer Res; 1986 Jun; 46(6):3196-9. PubMed ID: 2421891
[TBL] [Abstract][Full Text] [Related]
23. Detection of N-myc gene amplification in bone marrow specimen of stage IV neuroblastoma patients.
Brack T; Scholz RB; Milde-Langosch K; Heinsohn S; Löning T; Kabisch H
Cancer Detect Prev; 1992; 16(3):185-92. PubMed ID: 1458508
[TBL] [Abstract][Full Text] [Related]
24. [Detection of n-myc gene amplification in neuroblastoma using polymerase chain reaction based methods].
Melegh Z; Bálint I; Nagy K; Magyarosy E; Galántai I; Szentirmay Z
Magy Onkol; 2002; 46(1):43-8. PubMed ID: 12050681
[TBL] [Abstract][Full Text] [Related]
25. Prognostic prediction in neuroblastomas: clinical significance of combined analysis for Ha-ras p21 expression and N-myc gene amplification.
Tanaka T; Seeger RC; Tanabe M; Hiyama E; Shimoda H; Ida N
Cancer Detect Prev; 1994; 18(4):283-9. PubMed ID: 7982238
[TBL] [Abstract][Full Text] [Related]
26. Preferential amplification of the paternal allele of the N-myc gene in human neuroblastomas.
Cheng JM; Hiemstra JL; Schneider SS; Naumova A; Cheung NK; Cohn SL; Diller L; Sapienza C; Brodeur GM
Nat Genet; 1993 Jun; 4(2):191-4. PubMed ID: 8102299
[TBL] [Abstract][Full Text] [Related]
27. Duplication of N-MYC at its resident site 2p24 may be a mechanism of activation alternative to amplification in human neuroblastoma cells.
Corvi R; Savelyeva L; Schwab M
Cancer Res; 1995 Aug; 55(16):3471-4. PubMed ID: 7627947
[TBL] [Abstract][Full Text] [Related]
28. N-myc gene amplification in rhabdomyosarcoma detected by fluorescence in situ hybridization: its correlation with histologic features.
Hachitanda Y; Toyoshima S; Akazawa K; Tsuneyoshi M
Mod Pathol; 1998 Dec; 11(12):1222-7. PubMed ID: 9872655
[TBL] [Abstract][Full Text] [Related]
29. Rapid and accurate determination of MYCN copy number and 1p deletion in neuroblastoma by quantitative PCR.
Anderson J; Gibson S; Williamson D; Rampling D; Austin C; Shipley J; Sebire N; Brock P
Pediatr Blood Cancer; 2006 Jun; 46(7):820-4. PubMed ID: 16220551
[TBL] [Abstract][Full Text] [Related]
30. Detection of amplified N-myc gene in neuroblastoma by in situ hybridization using the single-step silver enhancement method.
Noguchi M; Hirohashi S; Tsuda H; Nakajima T; Hara F; Shimosato Y
Mod Pathol; 1988 Nov; 1(6):428-32. PubMed ID: 3222254
[TBL] [Abstract][Full Text] [Related]
31. Identification of MYCN Copy Number Heterogeneity by Direct FISH Analysis of Neuroblastoma Preparations.
Squire JA; Thorner P; Marrano P; Parkinson D; Ng YK; Gerrie B; Chilton-Macneill S; Zielenska M
Mol Diagn; 1996 Dec; 1(4):281-289. PubMed ID: 10462574
[TBL] [Abstract][Full Text] [Related]
32. Chromosome abnormalities, cellular DNA content, oncogene amplification and growth pattern in agar culture of human neuroblastomas.
Carlsen NL; Mortensen BT; Andersson PK; Larsen JK; Nielsen OH; Tommerup N
Anticancer Res; 1991; 11(1):353-8. PubMed ID: 2018371
[TBL] [Abstract][Full Text] [Related]
33. [N-myc status of neuroblastoma from bone marrow cells].
Brack T; Finckenstein FG; Kabisch H
Klin Padiatr; 1991; 203(4):323-7. PubMed ID: 1942939
[TBL] [Abstract][Full Text] [Related]
34. Interphase fluorescence in situ hybridization is more sensitive than BIOMED-2 polymerase chain reaction protocol in detecting IGH-BCL2 rearrangement in both fixed and frozen lymph node with follicular lymphoma.
Belaud-Rotureau MA; Parrens M; Carrere N; Turmo M; Ferrer J; de Mascarel A; Dubus P; Merlio JP
Hum Pathol; 2007 Feb; 38(2):365-72. PubMed ID: 17134735
[TBL] [Abstract][Full Text] [Related]
35. Low-level copy gain versus amplification of myc oncogenes in medulloblastoma: utility in predicting prognosis and survival. Laboratory investigation.
Takei H; Nguyen Y; Mehta V; Chintagumpala M; Dauser RC; Adesina AM
J Neurosurg Pediatr; 2009 Jan; 3(1):61-5. PubMed ID: 19119907
[TBL] [Abstract][Full Text] [Related]
36. Enhanced expression of N-myc messenger RNA in neuroblastomas found by mass screening.
Matsunaga T; Shirasawa H; Hishiki T; Yoshida H; Kouchi K; Ohtsuka Y; Kawamura K; Etoh T; Ohnuma N
Clin Cancer Res; 2000 Aug; 6(8):3199-204. PubMed ID: 10955804
[TBL] [Abstract][Full Text] [Related]
37. Heterogeneity of MYCN amplification in a child with stroma-rich neuroblastoma (ganglioneuroblastoma).
Lorenzana AN; Zielenska M; Thorner P; Gerrie B; Weitzman S; Squire J
Pediatr Pathol Lab Med; 1997; 17(6):875-83. PubMed ID: 9353827
[TBL] [Abstract][Full Text] [Related]
38. The use of fine-needle aspiration cytology in the molecular characterization of neuroblastoma in children.
Fröstad B; Martinsson T; Tani E; Falkmer U; Darnfors C; Skoog L; Kogner P
Cancer; 1999 Apr; 87(2):60-8. PubMed ID: 10227595
[TBL] [Abstract][Full Text] [Related]
39. Alternative pathways of MYCN gene copy number increase in primary neuroblastoma tumors.
Valent A; Guillaud-Bataille M; Farra C; Lozach F; Spengler B; Terrier-Lacombe MJ; Valteau-Couanet D; Danglot G; Lenoir GM; Brison O; Bénard J; Bernheim A
Cancer Genet Cytogenet; 2004 Aug; 153(1):10-5. PubMed ID: 15325088
[TBL] [Abstract][Full Text] [Related]
40. Amplification of N-myc as a prognostic marker for patients with neuroblastoma.
Schwab M
Semin Cancer Biol; 1993 Feb; 4(1):13-8. PubMed ID: 8448374
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]